Does vitiligo shorten life expectancy?

The exact reason is not yet known, but several possibilities have been suggested.

First, the autoimmune response seen in vitiligo may have strengthened immune surveillance against certain diseases.

The immune reaction that attacks melanocytes may also suppress the development or growth of cancer cells. Indeed, previous studies have reported that vitiligo patients have a lower overall risk of developing cancer.

Second, vitiligo treatment itself may have a positive effect on overall health.

Narrowband UVB phototherapy used for vitiligo is known to potentially have positive effects on blood pressure, cardiovascular disease risk, inflammatory markers, and vitamin D synthesis.

Third, differences in lifestyle and healthcare utilization.

Vitiligo patients may adopt dietary adjustments, antioxidant intake, sunscreen use, and regular hospital visits to manage their condition, which could lead to early detection or management of other diseases.

However, these are only possible explanations, and this study alone cannot confirm the exact mechanism behind the lower risk of death in vitiligo patients.

There is no need to be overly concerned that vitiligo will shorten your life, but it should not be interpreted as a guarantee of longevity.

This study is meaningful because it analyzed overall and cause-specific mortality risk in vitiligo patients using large-scale national data.

Contrary to concerns that vitiligo patients may be more vulnerable to other serious diseases or have a shorter lifespan, the actual data showed a lower risk of death.

However, the study also has limitations.

Differences based on the severity or type of vitiligo were not separately analyzed, and the data were primarily based on patients who visited medical institutions.

Therefore, it is appropriate to understand this result as showing that “there is no evidence that vitiligo shortens lifespan” rather than “vitiligo leads to a longer life.”